These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. On the mechanism of mergocryptine-induced suppression of dopamine turnover in the rat striatum. Hashimoto T; Katsura M; Kuriyama K Eur J Pharmacol; 1991 Jun; 198(2-3):121-7. PubMed ID: 1864302 [TBL] [Abstract][Full Text] [Related]
8. Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: interactions with dopamine receptors of mammalian forebrain in vitro. Baldessarini RJ; Kula NS; Arana GW; Neumeyer JL; Law SJ Eur J Pharmacol; 1980 Oct; 67(1):105-10. PubMed ID: 7418727 [TBL] [Abstract][Full Text] [Related]
9. Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone. Sokoloff P; Martres MP; Schwartz JC Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):89-102. PubMed ID: 7207647 [No Abstract] [Full Text] [Related]
10. [3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain. Grigoriadis D; Seeman P Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):21-5. PubMed ID: 2869417 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3H]N-n-propylnorapomorphine binding sites. Dubois A; Scatton B Neurosci Lett; 1985 Jun; 57(1):7-12. PubMed ID: 3162114 [TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites. Agnati LF; Celani MF; Fuxe K Acta Physiol Scand; 1983 May; 118(1):79-81. PubMed ID: 6312748 [No Abstract] [Full Text] [Related]
13. Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides. Martres MP; Sokoloff P; Schwartz JC Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):116-23. PubMed ID: 6717609 [TBL] [Abstract][Full Text] [Related]
14. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum. Friend WC; Brown GM; Jawahir G; Lee T; Seeman P Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797 [TBL] [Abstract][Full Text] [Related]
15. Effects of GTP and sodium on rat striatal dopamine receptors labeled with lisuride. Uzumaki H; Govoni S; Memo M; Carruba MO; Trabucchi M; Spano PF Brain Res; 1982 Sep; 248(1):185-7. PubMed ID: 7127137 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine. Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732 [TBL] [Abstract][Full Text] [Related]
17. Binding of [3H]apomorphine to striatal membranes prepared from rat brain after 6-hydroxydopamine and kainic acid lesions. Fujita N; Saito K; Iwatsubo K; Hirata A; Noguchi Y; Yoshida H Brain Res; 1980 May; 190(2):593-6. PubMed ID: 7370810 [No Abstract] [Full Text] [Related]
18. Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes. Williams M; Totaro JA Eur J Pharmacol; 1982 Dec; 86(1):35-42. PubMed ID: 7160432 [TBL] [Abstract][Full Text] [Related]
19. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors. Seeman P; Woodruff GN; Poat JA Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412 [TBL] [Abstract][Full Text] [Related]
20. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding. Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]